Sign In

Login

Password

Forgot Password ? Sign Up

Lecanemab (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Lecanemab" in German language version.

refsWebsite
Global rank German rank
2doi.org
2nd place
3rd place
2nih.gov
4th place
7th place
2pharmazeutische-zeitung.de
8,614th place
583rd place
2europa.eu
68th place
29th place
2biogen.com
low place
low place
2fda.gov
447th place
751st place
1who.int
195th place
255th place
1bbc.com
20th place
57th place
1alzheimersresearchuk.org
low place
low place
1gov.uk
432nd place
770th place
1nytimes.com
7th place
19th place
1clinicaltrials.gov
5,225th place
2,461st place
1theguardian.com
12th place
25th place

alzheimersresearchuk.org

bbc.com

biogen.com

investors.biogen.com

clinicaltrials.gov

  • Eisai Inc.: A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease. NCT03887455. clinicaltrials.gov, 11. Juli 2022 (clinicaltrials.gov [abgerufen am 27. September 2022]).

doi.org

  • Lars Lannfelt, Christer Möller, Hans Basun, Gunilla Osswald, Dag Sehlin: Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease. In: Alzheimer's Research & Therapy. Band 6, Nr. 2, 24. März 2014, S. 16, doi:10.1186/alzrt246, PMID 25031633, PMC 4054967 (freier Volltext) – (englisch).
  • Sofia Söllvander, Elisabeth Nikitidou, Linn Gallasch, Marlena Zyśk, Linda Söderberg: The Aβ protofibril selective antibody mAb158 prevents accumulation of Aβ in astrocytes and rescues neurons from Aβ-induced cell death. In: Journal of Neuroinflammation. Band 15, 28. März 2018, S. 98, doi:10.1186/s12974-018-1134-4, PMID 29592816, PMC 5875007 (freier Volltext) – (englisch).

europa.eu

ema.europa.eu

fda.gov

gov.uk

nih.gov

ncbi.nlm.nih.gov

  • Lars Lannfelt, Christer Möller, Hans Basun, Gunilla Osswald, Dag Sehlin: Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease. In: Alzheimer's Research & Therapy. Band 6, Nr. 2, 24. März 2014, S. 16, doi:10.1186/alzrt246, PMID 25031633, PMC 4054967 (freier Volltext) – (englisch).
  • Sofia Söllvander, Elisabeth Nikitidou, Linn Gallasch, Marlena Zyśk, Linda Söderberg: The Aβ protofibril selective antibody mAb158 prevents accumulation of Aβ in astrocytes and rescues neurons from Aβ-induced cell death. In: Journal of Neuroinflammation. Band 15, 28. März 2018, S. 98, doi:10.1186/s12974-018-1134-4, PMID 29592816, PMC 5875007 (freier Volltext) – (englisch).

nytimes.com

  • Rebecca Robbins, Pam Belluck: Alzheimer’s Drug Slows Cognitive Decline in Key Study. In: The New York Times. 28. September 2022 (nytimes.com [abgerufen am 29. September 2022]).

pharmazeutische-zeitung.de

theguardian.com

who.int